Market Update: Merck & Co Inc (NYSE:MRK) – Merck to Present New Data at the European Cancer Congress 2015 Reinforcing the Company’s Patient-Centric Focus

[CNW Group] – Merck to Present New Data at the European Cancer Congress 2015 Reinforcing the Company’s Patient-Centric Focus Read more on this. Merck & Co. Inc. (MRK), valued at $146.92B, started . . . → Read More: Market Update: Merck & Co Inc (NYSE:MRK) – Merck to Present New Data at the European Cancer Congress 2015 Reinforcing the Company’s Patient-Centric Focus Similar Articles: Company Update (NYSE:MRK): Merck to Hold Second-Quarter 2015 Sales and Earnings Conference Call on July 28 Company Update: Merck & Co Inc (NYSE:MRK) – 2015 ASCO Annual Meeting: New Data in 10 Different Cancers from Merck’s Rapidly Expanding Immuno-Oncology Research Program for KEYTRUDA® (pembrolizumab) to be Presented Market Update: Merck & Co Inc (NYSE:MRK) – Merck to Hold First-Quarter 2015 Sales and Earnings Conference Call on April 28